跳至主要内容
临床试验/EUCTR2004-003238-32-AT
EUCTR2004-003238-32-AT进行中(未招募)不适用

Effect of pioglitazone on portal and systemic hemodynamics in patients with advanced cirrhosis - Cirrpio

Dept. of Clinical Pharmacology0 个研究点目标入组 20 人开始时间: 2004年11月8日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Patients (male and female) aged older than 18 years with advanced (Child´s Grade B or C) cirrhosis scheduled for hepatic hemodynamic investigation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -History of hypertensitivity to the trial drugs and contrast agent or to drugs with a similar chemical structure
  • -Treatment with vasoactive or non-steroidal anti-inflammatory drugs or systemic antibiotics one week before the study
  • -Exclusion criteras for hepatic hemodynamic investigation
  • -Cardiac, renal or respiratory failure
  • -previous surgical or transjugular intrahepatic portosystemic shunt
  • -insulin-dependent diabetes

研究者

发起方
Dept. of Clinical Pharmacology

相似试验